MARENGO
Live / Registered — Registered (as of 23 Dec 2025)
What this means for you
Registered since 23 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97111783
- Registration number
- 8078739
- Mark type
- Design + words
- Filed
- 05 Nov 2021
- Published for opposition
- 20 Sept 2022
- Registered
- 23 Dec 2025
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research in the fields of immunology and oncology; pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; research and development in immunology for the purpose of using antibodies to target malignant solid tumors and to promote protective tumor immunity; research and development in pharmacology for the purpose of triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; medical research services in the field of cancer; medical and scientific research in the field of cancer treatment; medical and scientific research for immune system activation and protection; research and development for the purpose of anti-cancer immune activation therapeutics; medical and scientific research in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; research and development of vaccines and medicines
Owner
- MARENGO THERAPEUTICS, INC., Cambridge, MA, US
- MARENGO THERAPEUTICS, INC., Cambridge, MA, US
- MARENGO THERAPEUTICS, INC., Cambridge, MA, US
Prosecution history
- 23 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Dec 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Dec 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Nov 2025 — USE AMENDMENT FILED
- 12 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 09 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Apr 2025 — SOU EXTENSION 5 GRANTED
- 07 Apr 2025 — SOU EXTENSION 5 FILED
- 07 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2025 — SOU EXTENSION 4 GRANTED
- 14 Nov 2024 — SOU EXTENSION 4 FILED
- 15 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL